.After raising $213 million in 2023-- among the year's most extensive private biotech shots-- Tome B...
.Accept to this week's Chutes & Ladders, our summary of considerable leadership hirings, firings ...
.Venture capital funding in to biopharma cheered $9.2 billion all over 215 sell the 2nd fourth of th...
.Bicara Rehabs and also Zenas Biopharma have provided new inspiration to the IPO market with filings...
.Genentech is going to close its own cancer cells immunology research team, and device mind and well...
.Kezar Lifestyle Sciences is actually dropping its unpromising phase 1 solid growth drug as the biot...
.Regardless of izokibep sustaining its newfound winning streak in the facility, Acelyrin is no longe...
.Rivus Pharmaceuticals has plumped up the prospects of its own fat-busting, muscle-sparing medicatio...
.Ovid Therapy already exposed final month that it was trimming back its own head count as the compan...
.Eli Lilly has actually opened up a $700 thousand R&D center in the Boston Seaport, increasing it...